Susquehanna International Group, LLP Lava Therapeutics Nv Call Options Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$1.57 - $2.29 $74,104 - $108,088	-47,200 Reduced 64.57%	25,900 $42,000
Q2 2024 Aug 15, 2024	BUY	$1.8 - $3.37 $99,720 - $186,698	55,400 Added 312.99%	73,100 $131,000
Q1 2024 May 07, 2024	SELL	$1.53 - $4.03 $6,120 - $16,120	-4,000 Reduced 18.43%	17,700 $58,000
Q4 2023 Feb 14, 2024	BUY	$1.17 - $1.58 $5,499 - $7,426	4,700 Added 27.65%	21,700 $34,000
Q3 2023 Nov 14, 2023	SELL	$1.47 - $2.06 $147 - $206	-100 Reduced 0.58%	17,000 $24,000
Q2 2023 Aug 11, 2023	BUY	$1.4 - $2.6 $23,940 - $44,460	17,100 New	17,100 $34,000

3.61M

32.9K

500

Ticker LVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,797,700
Market Cap $26.8M
Description
LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.